Fisher E R, Sass R, Fisher B
Cancer. 1987 May 1;59(9):1554-9. doi: 10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b.
Pathologic materials were available for review from 1597 women with Stage II (positive regional node metastases) invasive breast cancer in whom estrogen receptor (ER) and progesterone receptor (PR) assays of the primary tumor were performed. These women were enrolled in a clinical trial comparing the effect of postmastectomy adjuvant L-phenylalanine mustard (L-PAM) and 5-fluorouracil (5-FU) with and without tamoxifen (NSABP Protocol No. 9). Significant pathologic and clinical associations with receptor status were similar for both ER and PR except that the latter, unlike ER, was not related to patient age. Regression analyses revealed that the most significant pathologic features related to a concordant positive ERPR receptor status was low (well differentiated) nuclear and histologic grades, slight or absent tumor lymphoid infiltrate, slight or absent necrosis and moderate or marked elastica in decreasing order of importance. All of the factors enumerated are directly or indirectly related to tumor differentiation. Recognition of four or five conforming pathologic features allows for the prediction of either ER or PR status in 70% to 80% of instances respectively, and the presence of three features in 69%. This latter figure is similar to that of estimation of nuclear grade alone. Thirty percent of ERPR estimates were discordant i.e., either ER-PR+ or ER+PR-. Pathologic features associated with discordant assays were not similar to those found when the ERPR estimates were concordant. Life table analyses revealed patients with discordant receptors to exhibit disease-free survival intermediate to that of those with ER+PR+ and ER-PR- values. This information suggests that a discordant receptor status is more reflective of an aberration of ER metabolism than a methodologic error. Histograms correlating frequency of nuclear grades with levels of ER and PR were comparable and revealed patterns indicating the propriety of relating values less than 10 fm/mg as being receptor negative. The frequency of well-differentiated nuclei increased with ascending levels of ER and PR.
对1597例II期(区域淋巴结转移阳性)浸润性乳腺癌女性患者的病理材料进行了回顾,这些患者均接受了原发肿瘤的雌激素受体(ER)和孕激素受体(PR)检测。这些女性参与了一项临床试验,比较了乳房切除术后辅助使用左旋苯丙氨酸氮芥(L-PAM)和5-氟尿嘧啶(5-FU)加或不加他莫昔芬的效果(NSABP协议编号9)。除PR与患者年龄无关(与ER不同)外,ER和PR与受体状态的显著病理和临床关联相似。回归分析显示,与ERPR受体状态一致呈阳性最显著的病理特征按重要性递减顺序为低(高分化)核级和组织学分级、轻微或无肿瘤淋巴细胞浸润、轻微或无坏死以及中度或显著弹性组织,所有列举的因素均直接或间接与肿瘤分化相关。识别出四或五个符合的病理特征分别可在70%至80%的病例中预测ER或PR状态,识别出三个特征的情况占69%。后一数字与单独估计核级的数字相似。30%的ERPR估计结果不一致,即要么ER-PR+要么ER+PR-。与不一致检测相关的病理特征与ERPR估计结果一致时发现的特征不同。生命表分析显示,受体不一致的患者无病生存期介于ER+PR+和ER-PR-值的患者之间。该信息表明,不一致的受体状态更反映ER代谢异常而非方法学错误。将核级频率与ER和PR水平相关的直方图具有可比性,揭示了表明将小于10 fm/mg的值视为受体阴性合理的模式。高分化核的频率随ER和PR水平升高而增加。